Clinical Trial Update: PROGRESS Trial - Prophylactic Gabapentin for Relief of Symptoms and Improved Swallowing [Phase 2]

View source ↗

Summary

The PROGRESS trial evaluating prophylactic gabapentin to relieve symptoms and improve swallowing in oropharyngeal cancer (HPV-related oropharyngeal squamous cel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hpv-related Oropharyngeal Squamous Cell Carcinoma
• Oropharyngeal Cancer

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

Sponsor: University of Chicago | Conditions: Oropharyngeal Cancer, HPV-Related Squamous Cell Carcinoma | Phase 2 | Status: WITHDRAWN